University of Cambridge will keep its vet school open
Bottom line
CURRENT BRIEF VERSION: The University of Cambridge has decided to keep its veterinary medicine course open, rejecting a recommendation from its School of the Biological Sciences to end veterinary education after the final cohort would have graduated in 2032. In a statement published February 23, 2026, Cambridge’s General Board said the university will continue admitting students, with offer letters for autumn 2026 entry going out immediately. The board also said the vet school will need new leadership, further external analysis of future delivery models, and a financial and operational reorganization of clinical services. (cam.ac.uk)
Why it matters: For veterinary professionals, the decision preserves one of the UK’s established training pipelines at a time when workforce capacity, farm vet shortages, food security, public health resilience, and One Health preparedness are already under pressure. The British Veterinary Association welcomed the move, saying Cambridge plays a crucial role in producing homegrown veterinary talent, while the National Farmers’ Union said keeping the school open matters for regional and national farm-animal capacity. Other groups that had opposed closure, including the Royal College of Pathologists and the British Society of Veterinary Pathologists, had warned that losing Cambridge would weaken veterinary pathology, zoonotic disease preparedness, research capacity, and the supply of vets for public health and government roles. That said, the reprieve doesn’t erase the underlying issues: Cambridge’s degree remains under conditional accreditation from the Royal College of Veterinary Surgeons, which said in November 2025 that the program met only 27 of 77 standards in the prior review and must address remaining recommendations before the next visit in October 2026. (bva.co.uk)
What to watch: The next key milestone is Cambridge’s October 2026 RCVS accreditation visit, alongside the university’s promised work on leadership changes, cost savings, and alternative long-term training models. More broadly, watch whether Cambridge can turn the profession’s argument—that the school matters not just for teaching, but for pathology, research, and One Health infrastructure—into a sustainable operating plan. (rcvs.org.uk)
CURRENT FULL VERSION: The University of Cambridge has backed away from plans that could have ended its veterinary medicine program, deciding instead to keep the vet school open and continue admissions. In a February 23, 2026 statement, the university’s General Board said Cambridge will continue to admit students to the course, reversing the trajectory set in motion when the School of the Biological Sciences recommended in December 2025 that veterinary education should cease after the final cohort graduated in 2032. (cam.ac.uk)
That earlier recommendation grew out of two overlapping problems: accreditation pressure and money. The School of the Biological Sciences said the vet school had faced longstanding concerns around educational provision and the financial sustainability of its hospital, which it said had been losing more than £1 million a year and carrying an unsustainable accumulated trading deficit. The school also pointed to Cambridge’s small annual intake, around 65 students, as a structural constraint compared with larger UK programs. (bio.cam.ac.uk)
Regulatory pressure has been especially important. The Royal College of Veterinary Surgeons granted Cambridge’s degree conditional accreditation in November 2024 after a visit found it met only 27 of 77 accreditation standards, with 55 recommendations for improvement. After a follow-up visit in September 2025, the RCVS said progress had been made, but full accreditation still wasn’t warranted, so it extended conditional accreditation for one more year and set an October 2026 deadline for Cambridge to meet the remaining recommendations. If standards aren’t met, graduates could lose automatic eligibility for UK registration and instead need to pass the RCVS Statutory Membership Examination. (rcvs.org.uk)
Against that backdrop, the decision to keep the school open is more of a reprieve than a clean resolution. Cambridge’s General Board said the university will continue admissions, but it also called for new leadership at the vet school, said the School of the Biological Sciences cannot be solely responsible for its future, and ordered further analysis, with external experts, to develop alternative models for veterinary education at Cambridge. The board also endorsed immediate cost savings and a financial and operational reorganization of clinical services. The Department of Veterinary Medicine, in its own statement, said it had presented externally appraised alternatives for the West Cambridge site and wants to work with the university on a sustainable long-term plan. (cam.ac.uk)
The profession’s reaction has been broadly supportive, but cautious. The British Veterinary Association said it was pleased Cambridge had listened to concerns from across the profession, arguing that closure would have damaged the pipeline of highly skilled veterinary professionals and represented a risk to public health and scientific capacity. In January, BVA had coordinated an open letter with 19 other veterinary organizations calling the closure proposal “premature, flawed and short-sighted,” warning of knock-on effects for disease surveillance, food safety, animal welfare, and future pandemic preparedness. The National Farmers’ Union also welcomed the decision, saying there is already a national shortage of farm vets and that losing Cambridge would have weakened regional training capacity and practical links to agriculture. Opposition had also come from pathology and research groups: the Royal College of Pathologists and the British Society of Veterinary Pathologists said closure would reduce the number of veterinarians entering public health, government, and research roles, and would weaken animal health, zoonotic disease preparedness, and One Health research capacity. (bva.co.uk)
Why it matters: For veterinary professionals, this is a workforce and infrastructure story as much as an academic one. Cambridge is a relatively small program, but small programs can still matter outsizedly in referral care, research, farm-animal exposure, pathology, and leadership development. Keeping the school open helps avoid an immediate contraction in UK training capacity at a time when the profession is already debating shortages, retention, and public-sector resilience. It also preserves continuity for applicants, current students, referring clinicians, and pet parents who depend on tertiary services. More broadly, critics of closure argued that Cambridge’s role extends into One Health and national preparedness: not just training clinicians, but supporting veterinary pathology, zoonotic disease readiness, biomedical research, and the pipeline for government and public health work. (cam.ac.uk)
Still, the underlying lesson for the sector is harder: prestige doesn’t insulate a vet school from accreditation deficits, hospital losses, or governance strain. Cambridge now has to show that it can convert political and professional support into operational improvement. For veterinary educators and employers, the case is a reminder that workforce planning depends not just on keeping seats open, but on sustaining clinical caseload, teaching quality, student support, financially viable training models, and the wider research and public-health functions that veterinary schools support. That’s especially relevant in systems where universities are balancing public-good missions against increasingly tight budgets. (rcvs.org.uk)
What to watch: The next major test is the RCVS revisit in October 2026, when Cambridge will need to demonstrate it has addressed outstanding recommendations. Before then, watch for leadership changes, details on the promised reorganization of clinical services, and whether Cambridge settles on a long-term model that can satisfy both regulators and the university’s financial expectations. Also worth watching is whether the university’s eventual plan reflects the argument made by supporters across the profession: that Cambridge’s value proposition is broader than student numbers alone, spanning pathology, research, One Health collaboration, and national biosecurity capacity. (rcvs.org.uk)